Verano Holdings (VRNO) Free Cash Flow (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Free Cash Flow of $3.6 million for Q1 2026, up 130.22% year-over-year from $1.6 million in Q1 2025, and down 16.69% quarter-over-quarter from $4.4 million in Q4 2025.
Verano Holdings (VRNO) Free Cash Flow (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Free Cash Flow for 6 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 130.22% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $27.4 million (up 234.94% YoY), while the FY2025 annual figure was $11.6 million, down 11.55% from the prior year.
- Free Cash Flow slipped to $3.6 million in Q1 2026 per VRNO's latest filing, from $4.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $132.7 million in Q4 2022 and bottomed at -$84.8 million in Q3 2022.
- Historically, Free Cash Flow has averaged $13.0 million across 5 years, with a median of $8.3 million in 2023.
- On a YoY basis, Free Cash Flow climbed as much as 869.39% in 2022 and fell as far as 358.0% in 2022.
- Verano Holdings' Free Cash Flow stood at $132.7 million in 2022, then plunged by 59.37% to $53.9 million in 2023, then sank by 45.76% to $29.3 million in 2024, then tumbled by 85.03% to $4.4 million in 2025, then slipped by 16.69% to $3.6 million in 2026.
- Business Quant data shows VRNO's Free Cash Flow at $3.6 million in Q1 2026, $4.4 million in Q4 2025, and $18.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Verano Holdings | 449.04 Mn | 363.85 Mn | 99.70 Mn | 18.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.75 Mn |
| Jun 30, 2026 | 18.75 Mn |
| Mar 31, 2026 | 3.65 Mn |
| Mar 31, 2026 | 3.65 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Sep 30, 2025 | 18.90 Mn |
| Sep 30, 2025 | 18.90 Mn |
| Jun 30, 2025 | 431,000.00 |
| Jun 30, 2025 | 431,000.00 |
| Mar 31, 2025 | -12.08 Mn |
| Mar 31, 2025 | -12.08 Mn |
| Dec 31, 2024 | 29.26 Mn |
| Dec 31, 2024 | 29.26 Mn |
| Sep 30, 2024 | -26.86 Mn |
| Sep 30, 2024 | -26.86 Mn |
| Jun 30, 2024 | -10.60 Mn |
| Jun 30, 2024 | -10.60 Mn |
| Mar 31, 2024 | 21.34 Mn |
| Mar 31, 2024 | 21.34 Mn |